首页> 外文期刊>Journal of refractive surgery >Conductive keratoplasty for presbyopia: 3-year results.
【24h】

Conductive keratoplasty for presbyopia: 3-year results.

机译:老花眼的传导性角膜移植术:3年结果。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To assess the long-term safety, efficacy, and stability of conductive keratoplasty (CK) in the treatment of presbyopia. METHODS: Ten near-plano presbyopic patients (6 women and 4 men) underwent unilateral CK with standard-pressure technique in the non-dominant eye to improve their near vision. Mean age was 51+/-3.1 years (range: 46 to 56 years). Nine of the 10 patients were available for both 1- and 3-year follow-up examinations. RESULTS: Preoperative mean manifest refraction spherical equivalent (MRSE) was -0.17+/-0.29 diopters (D), yielding a mean near uncorrected visual acuity (UCVA) of J10. Three years after CK, the mean near UCVA was J3. The mean MRSE at 3 years was -1.06+/-0.81 D, which represents a 0.25 D change from the MRSE at 1 year. The MRSE in the dominant untreated eyes had a +0.26 D change during the 3-year period, which was not statistically different when compared to the CK-treated eyes during the 3-year postoperative period. No eye lost best spectacle-corrected visual acuity or had induced cylinder > or =0.75 D. Seventy-eight percent had binocular distance UCVA 20/20 or better and near UCVA J3 or better. The average keratometry remained stable at 45.09 D 3 years postoperatively compared to 45.08 D 1 year postoperatively. CONCLUSIONS: Conductive keratoplasty for the treatment of presbyopia provided safe, effective, predictable, and stable results 3 years following the initial surgery. Refractive stability was similar for both the CK-treated and untreated eyes with a small hyperopic shift noted during the 3-year follow-up period.
机译:目的:评估传导性角膜移植术(CK)在老花眼治疗中的长期安全性,疗效和稳定性。方法:10例近平面老花眼患者(6例女性和4例男性)在非优势眼中采用标准压力技术进行单侧CK手术,以改善其近视力。平均年龄为51 +/- 3.1岁(范围:46至56岁)。 10名患者中有9名可以进行1年和3年的随访检查。结果:术前平均眼球屈光度等效值(MRSE)为-0.17 +/- 0.29屈光度(D),得出J10的平均近矫正视力(UCVA)。 CK后三年,UCVA附近的平均值为J3。 3年的平均MRSE为-1.06 +/- 0.81 D,与1年的MRSE相差0.25D。未治疗的优势眼在3年期间的MRSE变化为+0.26 D,与术后3年的CK治疗的眼睛相比,无统计学差异。没有眼睛失去最佳的眼镜矫正视力,也没有诱发圆柱度大于或等于0.75D。78%的人的双眼距离UCVA为20/20或更高,并且接近UCVA J3或更高。术后3年的平均角膜曲率保持稳定在45.09 D,而术后1年为45.08D。结论:角膜移植术治疗老花眼可在首次手术后3年提供安全,有效,可预测和稳定的结果。在3年的随访期间,经CK处理的眼睛和未经治疗的眼睛的屈光稳定性相似,但远视移位较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号